Konstantin Mitov
Overview
Explore the profile of Konstantin Mitov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitkova Z, Stanimirova D, Manova M, Gerasimov N, Mitov K, Petrova G
Healthcare (Basel)
. 2025 Feb;
13(3).
PMID: 39942512
Background: Type 2 diabetes is a chronic disease with high global prevalence and significant social and economic burden. The pandemic affected patients' diagnostics and medicines dispensing. Diabetes was among the...
2.
Stoeva V, Mihaylov G, Mitov K, Petrova G, Tachkov K
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894452
The aim of this study was to analyze the therapeutic results and survival of patients with myelofibrosis treated with ruxolitinib in comparison with a group on standard therapy. It is...
3.
Stoeva V, Petrova G, Mitov K, Tachkov K
Pharmaceuticals (Basel)
. 2023 Jul;
16(7).
PMID: 37513888
We aimed to explore symptom severity and adherence to therapy for patients with myelofibrosis treated with ruxolitinib in Bulgaria. It is a prospective, non-interventional study performed at the specialized hospital...
4.
Adherence to Acromegaly Treatment and Analysis of the Related Factors-A Real-World Study in Bulgaria
Kamusheva M, Vandeva S, Mitov K, Parvanova A, Pesheva M, Ganov N, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839760
The purpose was to assess the level of medication adherence (MA) and related factors among individuals with acromegaly. The secondary goal was to assess the quality of life of patients...
5.
Krustev T, Milushewa P, Tachkov K, Mitov K, Petrova G
Front Public Health
. 2023 Jan;
10:1023171.
PMID: 36620233
Objective: This study aims to evaluate the use of STOPP/START criteria in the identification of Potentially inappropriate medication and potential prescribing omissions in older patients with cardiovascular diseases in Bulgaria....
6.
Boyadzhieva V, Tachkov K, Stoilov N, Mitov K, Stoilov R, Petrova G
Rheumatol Int
. 2022 Jun;
42(10):1775-1783.
PMID: 35759028
The aim of this study was to analyze the therapeutic results of rheumatoid arthritis (RA) therapy with different biologic disease-modifying antirheumatic drugs (bDMARDs) and the first Janus-activated kinase (JAK) inhibitor...
7.
Kamusheva M, Vandeva S, Mitov K, Rusenova Y, Elenkova A, Zacharieva S, et al.
Front Public Health
. 2020 May;
8:147.
PMID: 32411649
Acromegaly and its comorbidities affect the patients' quality of life, each healthcare system and the society. This study aimed to evaluate clinical characteristics and treatment patterns and the economic burden...
8.
Tachkov K, Mitov K, Koleva Y, Mitkova Z, Kamusheva M, Dimitrova M, et al.
PLoS One
. 2020 May;
15(5):e0232815.
PMID: 32392235
Aims: To evaluate the expected life expectancy in patients with diabetes in Bulgaria and to compare it to the expected life expectancy of the non-diabetic population in the country. Methods:...
9.
Mitkova Z, Mitov K, Valov V, Manova M, Savova A, Kamusheva M, et al.
Front Pharmacol
. 2019 May;
10:364.
PMID: 31040779
Aim: Incretins [dipeptidyl peptidase-4 inhibitors (DPP-4i) and glucagon-like peptide 1 RA (GLP-1 RA)] and sodium-glucose cotransporter-2 inhibitors (SGLT-2i) groups are now routinely used for type 2 diabetes therapy and comprise...
10.
Tachkov K, Kamusheva M, Mitov K, Doneva M, Petrova G
Front Public Health
. 2019 Apr;
7:70.
PMID: 30984734
The goal of the current study is to perform a pilot study of the cost of some oncohematology diseases in Bulgaria. This is a pilot broader burden of disease research....